Clinical trials
5 active studies led by Enliven Therapeutics, of 5 in all
Source: ClinicalTrials.gov, Studies with Enliven Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Enliven Therapeutics in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Enliven Therapeutics or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Source: SEC EDGAR, Company filings, CIK 1672619. Retrieved 13 Nov 2026.
5 active studies led by Enliven Therapeutics, of 5 in all
Source: ClinicalTrials.gov, Studies with Enliven Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1672619.
Studies Enliven Therapeutics leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Enliven Therapeutics or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Enliven Therapeutics: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Enliven Therapeutics is in.
Stories on the topics Enliven Therapeutics works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Vitamin D is made in sunlight, yet low levels are common even in sunny countries. How much you need, and when…
Read
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Read